Years of petitioning the DEA to remove cannabis from the controlled substance act have yielded no positive results, in spite of its proven and established therapeutic potential. This article originally appeared on Cannabis.net and has been reposted with permission. Imagine pushing for marijuana legislation for decades, just for a drug produced from a more potent and harmful controlled substance to receive more support from the DEA. Very few people would have guessed that the “cocaine versus cannabis” discussion would come to light this year, and fewer still would have guessed that it would be the Drug Enforcement Administration (DEA) working tirelessly to see that a cocaine-derived drug is rescheduled before cannabis on a federal level. Scheduling System in America The federal government of the U.S. authorizes the DEA to regulate all forms of drugs. The DEA is in charge of classifying or scheduling a drug depending on its therapeutic value and its potential to be abused. According to the DEA policies, drugs like cocaine and marijuana are scheduled due to their relative potential for abuse being higher than their medical value.
Terry Hacienda, The Fresh Toast, 12/06/2021 11:30:00
Open article: https://thefreshtoast.com/marijuana-legislation/will-the-dea-deschedule-a-cocaine-based-drug-before-marijuana/#utm_source=rss&utm_medium=rss&utm_campaign=will-the-dea-deschedule-a-cocaine-based-drug-before-marijuana